The global laboratory centrifuges market size was valued at USD 2.1 billion in 2025 and is projected to grow from USD 2.22 billion in 2026 to USD 3.47 billion by 2034, registering a CAGR of 5.74% during the forecast period from 2026 to 2034. North America dominated the laboratory centrifuges market with a market share of 38.4% in 2025.
A laboratory centrifuge is a specialized device used to separate substances of different densities within a liquid by spinning them at high speeds. This process, called centrifugation, applies centrifugal force to accelerate the separation of particles based on size, shape, and density. Laboratory centrifuges are widely used in medical, research, and industrial applications, such as blood sample separation, DNA extraction, and pharmaceutical development. They come in various types, including microcentrifuges, benchtop centrifuges, and ultracentrifuges, each designed for specific applications.
The global market is experiencing steady growth, driven by technological advancements, increasing research activities, and expanding diagnostic applications. The rising demand for high-speed and ultra-centrifuges across biotechnology, pharmaceutical, and clinical laboratories is fuelling market growth. Moreover, the growing prevalence of infectious diseases, cancer, and genetic disorders is driving the adoption of centrifuges in diagnostics, molecular biology, and proteomics research.
The market is also witnessing a shift towards smart and automated centrifuges, integrating AI, IoT, and cloud-based monitoring, enhancing efficiency, data management, and remote operation. Miniaturization and portable centrifuges are gaining traction, particularly in point-of-care testing and resource-limited settings, expanding accessibility.
Download a Free Sample To learn more about this report,
The adoption of smart centrifuges is rising with AI, IoT, and automation, enabling real-time monitoring, predictive maintenance, and remote operation. These innovations improve efficiency, reduce downtime, and enhance data management, making them ideal for biopharma, diagnostics, and genomics.
Such advancements in smart centrifuges are set to redefine separation technologies and innovation in biopharma, diagnostics, and research applications, boosting market growth.
The rise of high-speed and ultracentrifuges is a growing trend driven by the increasing demand for rapid and precise sample separation in genomics, proteomics, drug discovery, and biopharmaceutical manufacturing. These advanced centrifuges offer higher g-force, improved efficiency, and enhanced automation, making them essential for high-throughput research and clinical applications.
This trend is expected to revolutionize laboratory workflows, enhancing accessibility, efficiency, and real-time diagnostics across diverse healthcare and research settings.
An increased research and development expenditure leads to the demand for laboratory centrifuges, especially in biotechnology, pharmaceutical, and academic markets. High-quality centrifuges are required for sample preparation, separation, and testing by labs with rising global research expenditure, particularly in biotechnology and life sciences.
The expansion of genomics and proteomics research is driving demand for high-speed and ultracentrifuges in DNA/RNA extraction, protein isolation, and biomarker discovery. Advances in next-generation sequencing (NGS), personalized medicine, and drug development require precise centrifugation for sample preparation and purification.
With the rise in biopharma and industrial biotech expansion, the demand for high-speed centrifuges grows, driving the market growth.
The high cost of laboratory centrifuges, including both initial investment and ongoing maintenance, remains a major barrier to market expansion. Advanced models, such as ultracentrifuges and floor-standing centrifuges, require significant capital expenditure, regular calibration, and costly repairs, increasing the total cost of ownership.
Moreover, specialized rotors, temperature controls, and automation features add to the financial burden. These expenses are particularly challenging for small and mid-sized laboratories, research institutions, and facilities in developing regions with limited budgets.
As a result, adoption rates remain constrained despite the rising demand for centrifugation in medical diagnostics, biotechnology, and pharmaceutical research.
The integration of IoT and cloud computing in centrifuges enables real-time monitoring, predictive maintenance, and remote diagnostics, enhancing efficiency and reducing downtime. This technology supports automated data logging and workflow optimization, boosting adoption in biopharma, diagnostics, and research labs amid increasing digital transformation.
Such integration of IoT and AI-driven automation is set to enhance efficiency, precision, and sustainability in centrifuges, creating market opportunities.
Benchtop centrifuges hold the largest market share due to their compact design, affordability, and versatility across clinical diagnostics, research laboratories, and biotech applications. Their ease of use, lower maintenance costs, and suitability for low- to medium-throughput applications make them highly preferred.
Request Customizationto receive a tailored report.
The diagnostics segment leads the market due to the essential role of centrifugation in blood testing, disease detection, and clinical sample processing. The rising prevalence of infectious diseases, cancer, and genetic disorders continues to drive demand for high-speed and automated centrifuges, improving workflow efficiency. Technological advancements, such as enhanced automation and faster processing speeds, further support the growing need for precise and rapid diagnostic solutions, making diagnostics a key driver of market expansion.
Hospitals and clinics represent the largest end-user segment for laboratory centrifuges, driven by the growing demand for clinical diagnostics, disease screening, and blood testing. The increasing incidence of chronic diseases, rising patient admissions, and expanding diagnostic laboratory networks contribute to market growth. Moreover, advancements in automated centrifuge technology enhance efficiency, reducing turnaround times for critical tests. As healthcare facilities prioritize precision and speed in diagnostics, the adoption of centrifuges in hospital-based labs continues to rise, further solidifying this segment's dominance.
Speak to an Analystto discuss market opportunities.
North America holds the dominant position in the global laboratory centrifuges market with 38.04% market share, driven by substantial R&D investments, a strong presence of pharmaceutical and biotechnology companies, and advanced laboratory infrastructure. The region benefits from the increasing demand for precision medicine, a rising number of diagnostic laboratories, and the widespread adoption of automation in laboratory workflows.
Moreover, government funding for life sciences research, a growing focus on personalized healthcare, and the rising incidence of chronic and infectious diseases further support market expansion. Strategic collaborations between research institutions and industry players continue to enhance technological advancements, reinforcing North America's market leadership.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia-Pacific is poised to register the fastest CAGR, fueled by rising healthcare investments, increasing R&D activities in biotechnology and pharmaceuticals, and the rapid expansion of diagnostic laboratories. The growing prevalence of chronic and infectious diseases is driving demand for advanced laboratory technologies. Moreover, government initiatives aimed at strengthening healthcare infrastructure, rising academic research activities, and the growing presence of contract research organizations (CROs) and contract manufacturing organizations (CMOs) contribute to market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Flow Cytometry Market Size, Share, Growth, Analysis, Report, 2034
Gene Synthesis Market Size, Share, Growth, Analysis, Report, 2034
Cell Surface Markers Detection Market Size, Share, Growth, 2034
Single-Use Assemblies Market Size, Share, Growth, Analysis, 2034
Cancer Microbiome Sequencing Market Size, Share, Growth, 2034
Inhaled Biologics Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com